Published in J Biol Chem on December 25, 1968
Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J Clin Microbiol (1980) 13.49
Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol (1983) 8.19
Isolation of the bacteriophage lambda receptor from Escherichia coli. J Bacteriol (1973) 7.67
Attachment of flagellar basal bodies to the cell envelope: specific attachment to the outer, lipopolysaccharide membrane and the cyoplasmic membrane. J Bacteriol (1971) 6.91
The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol (1978) 6.03
Role of Agrobacterium cell envelope lipopolysaccharide in infection site attachment. Infect Immun (1976) 4.16
Ampicillin-resistant mutants of Escherichia coli K-12 with lipopolysaccharide alterations affecting mating ability and susceptibility to sex-specific bacteriophages. J Bacteriol (1971) 3.11
Plasmid-dependent attachment of Agrobacterium tumefaciens to plant tissue culture cells. Infect Immun (1978) 3.09
Transfer of palmitate from phospholipids to lipid A in outer membranes of gram-negative bacteria. EMBO J (2000) 2.64
Dissociation and reassembly of Escherichia coli outer membrane and of lipopolysaccharide, and their reassembly onto flagellar basal bodies. J Bacteriol (1971) 2.44
Binding of metals to cell envelopes of Escherichia coli K-12. Appl Environ Microbiol (1981) 2.42
Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane. Antimicrob Agents Chemother (1984) 2.37
Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes. J Clin Invest (1977) 2.07
Bacterial polysaccharide which binds Rhizobium trifolii to clover root hairs. J Bacteriol (1979) 2.06
Outer penetration barrier of Escherichia coli K-12: kinetics of the uptake of gentian violet by wild type and envelope mutants. J Bacteriol (1973) 2.02
Colicin tolerance induced by ampicillin or mutation to ampicillin resistance in a strain of Escherichia coli K-12. J Bacteriol (1971) 1.96
Murein and the outer penetration barrier of Escherichia coli K-12, Proteus mirabilis, and Pseudomonas aeruginosa. J Bacteriol (1972) 1.95
Bacterial lipopolysaccharides as inducers of disease resistance in tobacco. Appl Environ Microbiol (1977) 1.95
Puromycin-resistant biosynthesis of a specific outer-membrane lipoprotein of Escherichia coli. J Bacteriol (1976) 1.85
A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum. J Bacteriol (1982) 1.84
Use of transferrin-iron enterobactin complexes as the source of iron by serum-exposed bacteria. Infect Immun (1977) 1.82
Congo red agar, a differential medium for Aeromonas salmonicida, detects the presence of the cell surface protein array involved in virulence. J Bacteriol (1985) 1.81
Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol (1986) 1.80
Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med (1974) 1.74
Some characteristics of the outer membrane material released by growing enterotoxigenic Escherichia coli. Infect Immun (1980) 1.70
Filtration removal of endotoxin (pyrogens) in solution in different states of aggregation. Appl Environ Microbiol (1977) 1.63
Proteins released from cell envelopes of Pseudomonas aeruginosa on exposure to ethylenediaminetetraacetate: comparison with dimethylformamide-extractable proteins. J Bacteriol (1973) 1.63
Architecture of the outer membrane of Escherichia coli. III. Protein-lipopolysaccharide complexes in intramembraneous particles. J Bacteriol (1978) 1.53
Resistance of Escherichia coli to penicillins. 8. Physiology of a class II ampicillin-resistant mutant. J Bacteriol (1970) 1.52
Outer-membrane penetration barriers as components of intrinsic resistance to beta-lactam and other antibiotics in Escherichia coli K-12. Antimicrob Agents Chemother (1979) 1.50
Protective role of smooth lipopolysaccharide in the serum bactericidal reaction. Infect Immun (1971) 1.49
Environmental modulation of lipopolysaccharide chain length alters the sensitivity of Escherichia coli to the neutrophil bactericidal/permeability-increasing protein. Infect Immun (1986) 1.48
Rapid method for isolation of large quantities of outer membrane from Escherichia coli K-12 and its application to the study of envelope mutants. J Bacteriol (1973) 1.47
Mode of insertion of lipopolysaccharide into the outer membrane of escherichia coli. J Bacteriol (1976) 1.42
Sensitization of complement-resistant smooth gram-negative bacterial strains. Infect Immun (1971) 1.38
Basis for serological heterogeneity of thermostable antigens of Campylobacter jejuni. Infect Immun (1985) 1.30
Partial Removal of Lipopolysaccharide from Thiobacillus ferrooxidans Affects Its Adhesion to Solids. Appl Environ Microbiol (1994) 1.27
Detection of Escherichia coli antigens by a latex agglutination test. Appl Microbiol (1974) 1.25
Congo red binding and salt aggregation as indicators of virulence in Shigella species. J Clin Microbiol (1988) 1.24
Comparison of lipopolysaccharides from Agmenellum quadruplicatum to Escherichia coli and Salmonella typhimurium by using thin-layer chromatography. J Bacteriol (1975) 1.22
Release of membrane components from viable Haemophilus parainfluenzae by ethylenediaminetetraacetic acid-tris(hydroxymethyl)-aminomethane. J Bacteriol (1970) 1.22
Antigenicity of Helicobacter pylori lipopolysaccharides. J Clin Microbiol (1992) 1.19
Isolation of outer membranes with an ordered array of surface subunits from Acinetobacter. J Bacteriol (1973) 1.18
Susceptibility of whole cells and spheroplasts of Pseudomonas aeruginosa to actinomycin D. Antimicrob Agents Chemother (1973) 1.17
Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. Antimicrob Agents Chemother (2005) 1.12
Effect of ethylenediaminetetraacetate upon the surface of Escherichia coli. J Bacteriol (1977) 1.12
The effect of ethylenediaminetetra-acetate on Pseudomonas alcaligenes and the composition of the bacterial cell wall. Biochem J (1970) 1.12
Selective release of proteins from Spirillum itersonii by tris (hydroxymethyl) aminomethane and ethylenediaminetetraacetate. J Bacteriol (1971) 1.08
Plasmid-associated resistance of Salmonella typhimurium to complement activated by the classical pathway. Infect Immun (1987) 1.07
Latex test for quantitative determination of Escherichia coli antibody. Appl Microbiol (1974) 1.07
Cell surface protein of Pseudomonas (Hydrogenomonas) facilis. J Bacteriol (1973) 1.07
Effect of ethylenediaminetetraacetate on phospholipids and outer membrane function in Escherichia coli. J Bacteriol (1979) 1.06
Release of outer membrane fragments from wild-type Escherichia coli and from several E. coli lipopolysaccharide mutants by EDTA and heat shock treatments. J Bacteriol (1989) 1.06
Relation of R factor and chromosomal beta-lactamase with the periplasmic space. J Bacteriol (1974) 1.03
Relation between protein synthesis and phospholipid synthesis and turnover in Escherichia coli. J Bacteriol (1972) 1.01
Antigen distribution in a latex suspension and its relationship to test sensitivity. J Clin Microbiol (1976) 0.97
Relation of lipopolysaccharide and fatty acid ester release to the ethylenediaminetetraacetic acid alteration of permeability in enterobacteriaceae. J Bacteriol (1970) 0.97
Subcellular Localization of Salmonella enteritidis Endotoxin in Liver and Spleen of Mice and Rats. Infect Immun (1970) 0.95
Mutation in Shigella flexneri 2a resulting in increased electrophoretic mobility. Infect Immun (1972) 0.93
Interaction of Escherichia coli with polymorphonuclear leukocytes in pathogenesis of urinary tract infection in mice. Infect Immun (1988) 0.93
Introduction of proteins into living bacterial cells: distribution of labeled HU protein in Escherichia coli. J Bacteriol (1991) 0.91
Osmotic pressure in Escherichia coli as rendered detectable by lysozyme attack. J Bacteriol (1973) 0.91
Capacity of the outer membrane of a gram-negative marine bacterium in the presence of cations to prevent lysis by Triton X-100. J Bacteriol (1975) 0.90
Coupling of Escherichia coli lipopolysaccharide to epoxy-activated Sepharose 6B. Infect Immun (1978) 0.88
Detection of complement fixation by enzyme linked immunosorbant assay (COMPELISA). J Clin Pathol (1983) 0.87
Development of a blocking enzyme-linked immunosorbent assay for detection of serum antibodies to O157 antigen of Escherichia coli. Clin Diagn Lab Immunol (1998) 0.86
Murine monoclonal antibodies specific for lipopolysaccharide of Escherichia coli O26 and O111. Appl Environ Microbiol (2000) 0.85
Composition of the antigenic material removed from Campylobacter jejuni by heat. J Clin Microbiol (1984) 0.84
Delayed lysis with salmonella bacteriophage p22: induction of lysis by addition of cysteine or histidine to the growth medium. J Virol (1969) 0.84
Distribution of lipopolysaccharide and the detection of a new subfraction in the cell envelope of a marine pseudomonad. J Bacteriol (1977) 0.83
Enhanced susceptibility of Escherichia coli to intracellular killing by human polymorphonuclear leukocytes after in vitro incubation with chloramphenicol. Antimicrob Agents Chemother (1981) 0.82
Effects of certain cations (Fe, Zn, Mg, and Ca) on bacterial endotoxins. Infect Immun (1978) 0.81
Antibody- and complement-dependent cell injury assayed by 51Cr release from human peripheral blood mononuclear cells pretreated with lipopolysaccharide. Infect Immun (1987) 0.80
Fusion of small unilamellar vesicles with viable EDTA-treated Escherichia coli cells. J Bacteriol (1989) 0.79
The adsorption of endotoxin molecule in a microporous polyethylene hollow fibre membrane. J Hyg (Lond) (1986) 0.79
QMix® irrigant reduces lipopolysacharide (LPS) levels in an in vitro model. J Appl Oral Sci (2015) 0.79
Optimizing antibody expression by using the naturally occurring framework diversity in a live bacterial antibody display system. Sci Rep (2015) 0.79
Reconstitution of colicin E2-induced deoxyribonucleic acid degradation in spheroplast preparations. Antimicrob Agents Chemother (1973) 0.79
Bacteriophage T4D receptor and the Escherichia coli cell wall structure: binding of endotoxin-like particles to the cell wall. J Bacteriol (1980) 0.78
Highly purified mussel adhesive protein to secure biosafety for in vivo applications. Microb Cell Fact (2014) 0.76
Removal of endotoxin from water by microfiltration through a microporous polyethylene hollow-fiber membrane. Appl Environ Microbiol (1986) 0.75
Quantitation of the action of ethylenediaminetetracetic acid and tris(hydroxymethyl)aminomethane on a gram-negative bacterium by vancomycin adsorption. J Bacteriol (1970) 0.75
Comparison of the antigenicity of phenol and ethylenediaminetetraacetate complexes isolated from cell walls of Salmonella enteritidis. Appl Microbiol (1972) 0.75
Thermodynamic and kinetic studies of the interaction between T5-phages and their receptor, isolated from Escherichia coli b, in the absence and presence of Triton X-100. Biophys J (1981) 0.75
Lipopolysaccharide from a gram-negative marine bacterium. J Bacteriol (1974) 0.75
Heterogeneity of antigenic-side-chain length in lipopolysaccharide from Escherichia coli 0111 and Salmonella typhimurium LT2. Eur J Biochem (1980) 8.02
Release of lipopolysaccharide by EDTA treatment of E. coli. Biochem Biophys Res Commun (1965) 7.38
The barrier function of the gram-negative envelope. Ann N Y Acad Sci (1974) 6.08
Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate. J Biol Chem (1968) 6.06
Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci U S A (1981) 4.89
Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. J Biol Chem (1975) 4.80
Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors. J Immunol (1972) 4.38
Effect of virus infections on the function of the immune system. Annu Rev Microbiol (1970) 4.30
Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components. J Exp Med (1968) 4.19
Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun (1980) 3.41
Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes. J Exp Med (1968) 3.33
Synthesis, utilization and degradation of lactose operon mRNA in Escherichia coli. J Mol Biol (1967) 3.13
Collagenase production by endotoxin-activated macrophages. Proc Natl Acad Sci U S A (1974) 3.05
Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor. Infect Immun (1970) 3.01
Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science (1972) 2.91
Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens. J Exp Med (1967) 2.87
Two mutations which affect the barrier function of the Escherichia coli K-12 outer membrane. J Bacteriol (1979) 2.77
Collagenase production by lymphokine-activated macrophages. Science (1975) 2.64
Electron microscopic localization of endotoxic lipopolysaccharide in gram-negative organisms. Ann N Y Acad Sci (1966) 2.61
Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today (1989) 2.56
A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin. J Immunol (1969) 2.54
Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide. J Immunol (1979) 2.39
The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. Int Arch Allergy Appl Immunol (1968) 2.38
An equilibrium between two fractions of lipopolysaccharide in Escherichia coli. Proc Natl Acad Sci U S A (1968) 2.33
A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes. J Immunol (1973) 2.18
Significance of complement to the mechanism of action of endotoxin. Curr Top Microbiol Immunol (1969) 2.18
Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates. J Exp Med (1971) 2.15
Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells. Infect Immun (1980) 2.12
Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen. J Bacteriol (1984) 2.12
The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. J Infect Dis (1980) 2.11
Prostaglandin regulation of macrophage collagenase production. Proc Natl Acad Sci U S A (1977) 1.96
Lesions in Escherichia coli membranes after action of antibody and complement. J Bacteriol (1966) 1.94
Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen. J Immunol (1983) 1.90
Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes. J Immunol (1972) 1.90
Interactions of the complement system with native and chemically modified endotoxins. J Bacteriol (1968) 1.87
Controlling EDTA treatment to produce permeable Escherichia coli with normal metabolic processes. Biochem Biophys Res Commun (1967) 1.85
A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum. J Bacteriol (1982) 1.84
Decreased properdin activity in acute glomerulonephritis. Int Arch Allergy Appl Immunol (1969) 1.83
C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol (1986) 1.82
Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol (1986) 1.80
Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens. J Exp Med (1979) 1.73
Release of lipopolysaccharide in Escherichia coli resistant to the permeability increase induced by ethylenediaminetetraacetate. J Biol Chem (1970) 1.72
Elevated gamma-globulin and increased antibody production in mice infected with lactic dehydrogenase virus. J Exp Med (1966) 1.71
Factors from saliva and oral bacteria, chemotactic for polymorphonuclear leukocytes: their possible role in gingival inflammation. J Periodontol (1970) 1.66
Importance of Actinomyces and certain gram-negative anaerobic organisms in the transformation of lymphocytes from patients with periodontal disease. Infect Immun (1976) 1.62
In vitro transformation of mouse bone-marrow-derived (B) lymphocytes induced by the lipid component of endotoxin. Infect Immun (1973) 1.62
Macrophage-lymphocyte synergy in the production of osteoclast activating factor. J Immunol (1974) 1.61
The transport of diaminopimelate and cystine in Escherichia coli. J Biol Chem (1965) 1.58
Complement-dependent biological functions in complement deficiency in man. Lancet (1966) 1.56
Effect of variations in lipopolysaccharide on the fluidity of the outer membrane of Escherichia coli. J Biol Chem (1977) 1.56
Resistance of macrophages from C3H/HeJ mice to the in vitro cytotoxic effects of endotoxin. J Immunol (1977) 1.56
Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med (1991) 1.55
In vitro studies of a chemotactic lymphokine in the guinea pig. Int Arch Allergy Appl Immunol (1974) 1.46
Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J Immunol (1982) 1.45
Significant contribution of spleen cells in mediating the lethal effects of endotoxin in vivo. Infect Immun (1976) 1.44
Mode of insertion of lipopolysaccharide into the outer membrane of escherichia coli. J Bacteriol (1976) 1.42
Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide. Infect Immun (1984) 1.42
Decreased C'-1q protein concentration and agglutinating activity in agammaglobulinaemia syndromes: an inborn error reflected in the complement system. Clin Exp Immunol (1968) 1.41
Type 2 fimbrial lectin-mediated phagocytosis of oral Actinomyces spp. by polymorphonuclear leukocytes. Infect Immun (1986) 1.40
Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Infect Immun (1983) 1.34
Complement-dependent stimulation of prostaglandin synthesis and bone resorption. Science (1974) 1.31
Differential endotoxin sensitivity of lymphocytes and macrophages from mice with an X-linked defect in B cell maturation. J Immunol (1978) 1.30
Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length. J Immunol (1984) 1.28
The function and distribution of different fimbriae on strains of Actinomyces viscosus and Actinomyces naeslundii. J Dent Res (1984) 1.27
Interactions of the complement system with endotoxins from a Salmonella minnesota mutant deficient in O-polysaccharide and heptose. J Immunol (1968) 1.27
Bactericidal antibody in mammalian serum to obligatorily anaerobic Gram-negative bacteria. J Immunol (1966) 1.27
Inflammation and herpes simplex virus: release of a chemotaxis-generating factor from infected cells. Science (1970) 1.27
Increased thymocyte-activating factor in human gingival fluid during gingival inflammation. Infect Immun (1982) 1.27
Release from Escherichia coli of a galactosyltransferase complex active in lipopolysaccharide synthesis. J Biol Chem (1970) 1.27
Identification of outer membrane proteins, including known lymphocyte mitogens, as the endotoxin protein of Escherichia coli 0111. J Immunol (1981) 1.27
Apoptosis in human monocytes: possible role in chronic inflammatory diseases. J Periodontol (1993) 1.26
A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4. J Immunol (1984) 1.26
Humoral mediators of chemotaxis of mononuclear leukocytes. J Infect Dis (1972) 1.26
Inhibition of cellular immune reactions in mice infected with lactic dehydrogenase virus. Nature (1969) 1.25
Tetracyclines of various hydrophobicities as a probe for permeability of Escherichia coli outer membranes. Antimicrob Agents Chemother (1984) 1.25
Defective prostaglandin synthesis by C3H/HeJ mouse macrophages stimulated with endotoxin preparations. Infect Immun (1979) 1.16
Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. J Immunol (1983) 1.12
Effect of ethylenediaminetetraacetate upon the surface of Escherichia coli. J Bacteriol (1977) 1.12
A role for cell-mediated immunity in the pathogenesis of periodontal disease. J Periodontol (1974) 1.12
Tyrosine phosphorylation of pp125FAK by the aggregation of high affinity immunoglobulin E receptors requires cell adherence. J Biol Chem (1993) 1.12
Blastogenesis and lymphokine synthesis by T and B lymphocytes from patients with periodontal disease. Infect Immun (1974) 1.11
Interactions of the complement system with endotoxic lipopolysaccharides in immunoglobulin-deficient sera. J Exp Med (1970) 1.11
Enhanced humoral immunity in mice infected with attenuated Venezuelan equine encephalitis virus. J Immunol (1969) 1.10
Adjuvanticity of lactic dehydrogenase virus: influence virus infection on the establishment of immunologic tolerance to a protein antigen in adult mice. J Immunol (1967) 1.10
Lipopolysaccharide (LPS) regulation of the immune response: T lymphocytes from normal mice suppress mitogenic and immunogenic responses to LPS. J Immunol (1980) 1.09
Interactions of the complement system with endotoxic lipopolysaccharide: the generation of an anaphylatoxin. Immunology (1969) 1.06
A synthetic glycolipid with B-cell mitogenic activity. J Exp Med (1974) 1.05
Prostaglandin regulation of colony-stimulating factor production by lipopolysaccharide-stimulated murine leukocytes. Infect Immun (1979) 1.04
Differential regulation of colony-stimulating factors and interleukin 2 production by cyclosporin A. Proc Natl Acad Sci U S A (1987) 1.02
Evidence for a gradient of exogenous and endogenous diaminopimelate in Escherichia coli. J Biol Chem (1965) 1.02
Separation of a serum-derived tumoricidal factor from a helper factor for plaque-forming cells. J Immunol (1980) 1.01
Immunologic reactions and periodontal inflammation. J Dent Res (1970) 1.01
Elaboration of lymphotoxin by cultured human peripheral blood leucocytes stimulated with dental-plaque deposits. Clin Exp Immunol (1973) 1.00
Prolongation of skin homografts by rabbit anti-mouse lymphocyte serum in mice rendered tolerant to rabbit gamma-globulin. J Immunol (1968) 0.99
Adherence of rat basophilic leukemia (RBL-2H3) cells to fibronectin-coated surfaces enhances secretion. J Immunol (1992) 0.99
Domains involving nonrandom distribution of lipopolysaccharide in the outer membrane of Escherichia coli. Proc Natl Acad Sci U S A (1977) 0.98
Measurement of antibody against human IgG by the neutralization of IgG-sensitized herpes simplex virus. J Immunol (1970) 0.98
Genetic control of in vivo sensitivity to lipopolysaccharide: evidence for codominant inheritance. J Immunol (1979) 0.97
Immune fever in the rabbit: responses of the hematologic and complement systems. J Immunol (1971) 0.96